Celldex Therapeutics Inc (CLDX)
37.77
-1.08
(-2.78%)
USD |
NASDAQ |
Apr 23, 16:00
37.77
0.00 (0.00%)
After-Hours: 20:00
Celldex Therapeutics Free Cash Flow: -109.11M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | -109.11M |
September 30, 2023 | -97.91M |
June 30, 2023 | -114.29M |
March 31, 2023 | -109.60M |
December 31, 2022 | -105.56M |
September 30, 2022 | -98.44M |
June 30, 2022 | -79.46M |
March 31, 2022 | -68.62M |
December 31, 2021 | -62.16M |
September 30, 2021 | -52.74M |
June 30, 2021 | -48.20M |
March 31, 2021 | -48.26M |
December 31, 2020 | -41.96M |
September 30, 2020 | -47.60M |
June 30, 2020 | -46.86M |
March 31, 2020 | -46.07M |
December 31, 2019 | -47.15M |
September 30, 2019 | -51.63M |
June 30, 2019 | -54.80M |
March 31, 2019 | -61.19M |
December 31, 2018 | -76.05M |
September 30, 2018 | -80.17M |
June 30, 2018 | -90.36M |
March 31, 2018 | -94.36M |
December 31, 2017 | -101.72M |
Date | Value |
---|---|
September 30, 2017 | -103.00M |
June 30, 2017 | -103.11M |
March 31, 2017 | -115.98M |
December 31, 2016 | -115.79M |
September 30, 2016 | -108.95M |
June 30, 2016 | -113.34M |
March 31, 2016 | -105.06M |
December 31, 2015 | -103.76M |
September 30, 2015 | -111.99M |
June 30, 2015 | -110.10M |
March 31, 2015 | -105.55M |
December 31, 2014 | -103.47M |
September 30, 2014 | -98.36M |
June 30, 2014 | -89.54M |
March 31, 2014 | -86.60M |
December 31, 2013 | -71.89M |
September 30, 2013 | -68.05M |
June 30, 2013 | -60.63M |
March 31, 2013 | -53.85M |
December 31, 2012 | -50.08M |
September 30, 2012 | -46.12M |
June 30, 2012 | -43.29M |
March 31, 2012 | -40.70M |
December 31, 2011 | -36.17M |
September 30, 2011 | -33.14M |
Free Cash Flow Range, Past 5 Years
-114.29M
Minimum
Jun 2023
-41.96M
Maximum
Dec 2020
-70.02M
Average
-54.80M
Median
Jun 2019
Free Cash Flow Benchmarks
ThermoGenesis Holdings Inc | -5.454M |
Perspective Therapeutics Inc | -37.98M |
Electromed Inc | 3.653M |
Xtant Medical Holdings Inc | -10.97M |
Asensus Surgical Inc | -64.19M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -32.53M |
Cash from Investing (Quarterly) | -171.16M |
Cash from Financing (Quarterly) | 217.37M |
Free Cash Flow Per Share (Quarterly) | -0.6376 |
Free Cash Flow to Equity (Quarterly) | -33.20M |
Free Cash Flow Yield | -5.96% |